Top Stories

Support On Patreon

Top Stories

Christopher Valore (AKA The Architect) talks “Conductor,” His Virtual-Reality, Psychedelic-Visual Sandbox Platform

Christopher Valore discusses his love of virtual reality; the early days of his company, Club Transcendia; and development of his first official release, “Conductor.”

An Open Letter and Call to Action for MAPS Canada

The following is an open letter by two former co-leads of the MAPS Canada Diversity Committee. It was written in response to a variety of racist and prejudicial behaviours they experienced from MAPS Canada leadership and the organization at large during their eight-month tenure as unpaid volunteers, including obstruction—by leadership—of their efforts to address long-entrenched discriminatory practices in the psychedelic research domain and to implement initiatives to combat race-based health disparities.

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”

Become a member.

Support Us On Patreon.


Livestream – November 19, 2020

We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

Chemical Poetics: Rebel Wisdom and the Psychedelic IDW

Neşe Devenot, PhD of Psymposia’s Plus Three podcast ventures into the psychedelic “arm” of the Intellectual Dark Web in this first episode of Chemical Poetics.


Series

Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.


Critical Takes

Magical (Psychedelic) Thinking in the Era of Climate Change and COVID-19

Two of our biggest crises—COVID-19 and climate change—lay bare the magical thinking that pervades psychedelic discourse: that individual experiences of oneness will necessarily transform our society for the better.

Dear Psychedelic Researchers

The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Lucy In The Sky With Nazis: Psychedelics and the Right Wing

Psychedelic advocates have long asserted that broader psychedelic use will lead to a more open, progressive society, but there are too many instances of right-wingers who have taken them for that to be true.

Amidst Pandemic, Psychedelic Investor Christan Angermayer Can’t Imagine Life Beyond Capitalism

As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

#29 – The Tesla of Mental Health?

Brian Normand and David Nickles are joined by Psymposia Senior Writer Russell Hausfeld to discuss MindMed's CEO, Jamon Rahn's, recent claims that his company "may be creating effectively the Tesla of mental health,” and that the company is now a "$1B+ Unicorn.”


From Mining to Mushrooms

A series exploring the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry.


Livestream – November 19, 2020

We kicked off the start of our ongoing livestreams with the announcement of Psymposia's 501(c)(3) non-profit status, discussions of corporadelic dynamics, fond memories of helping people learn how to extract psychedelic drugs during an Ivy League University's psychedelic conference, and a whole bunch of back and forth with the audience about the current state (and future) of psychedelia.

The LSD Silo Bust according to William Leonard Pickard

Neşe Devenot shares William Leonard Pickard's description of his side of the Silo bust in "The Rose of Paracelsus."


Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.


Corporadelic

A series on the intersection of psychedelics and capitalism, and the early investors making it happen.


Critical Takes

Magical (Psychedelic) Thinking in the Era of Climate Change and COVID-19

Two of our biggest crises—COVID-19 and climate change—lay bare the magical thinking that pervades psychedelic discourse: that individual experiences of oneness will necessarily transform our society for the better.

Amidst Pandemic, Psychedelic Investor Christan Angermayer Can’t Imagine Life Beyond Capitalism

As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”

Dear Psychedelic Researchers

The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.

Lucy In The Sky With Nazis: Psychedelics and the Right Wing

Psychedelic advocates have long asserted that broader psychedelic use will lead to a more open, progressive society, but there are too many instances of right-wingers who have taken them for that to be true.